Filing Details
- Accession Number:
- 0001437749-16-025031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-09 16:09:13
- Reporting Period:
- 2016-02-09
- Filing Date:
- 2016-02-09
- Accepted Time:
- 2016-02-09 16:09:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
72444 | Biota Pharmaceuticals Inc. | BOTA | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1040766 | P Mark Colonnese | 2500 Northwinds Parkway Ste 100 Alpharetta GA 30009 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-02-09 | 300 | $1.40 | 300 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-02-09 | 6,700 | $1.41 | 7,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |